HES
61
2
CF
35
3
ALL
54
-4
URI
46
3
UHS
55
-3
CTAS
40
-5
BMY
45
-6
JBHT
38
2
WBA
50
2
DGX
47
3
LH
46
8
APA
25
2
MKC
66
-2
AMP
58
3
CRM
35
3
APH
48
2
AFL
49
-3
SJM
28
-6
NTRS
47
2
GIS
57
-4
HES
61
2
CF
35
3
ALL
54
-4
URI
46
3
UHS
55
-3
CTAS
40
-5
BMY
45
-6
JBHT
38
2
WBA
50
2
DGX
47
3
LH
46
8
APA
25
2
MKC
66
-2
AMP
58
3
CRM
35
3
APH
48
2
AFL
49
-3
SJM
28
-6
NTRS
47
2
GIS
57
-4
Financhill
Back

Idaho Strategic Resources Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
63

IDR
Idaho Strategic Resources

Last Price:
$12.35
Seasonality Move:
5.78%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.65
Seasonality Move:
6.73%
Buy
63
Idaho Strategic Resources (IDR) is a Buy

Is Idaho Strategic Resources a Buy, Sell or Hold?

  • The current Idaho Strategic Resources [IDR] share price is $11.51. The Score for IDR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • IDR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IDR Stock Price Chart

What is Idaho Strategic Resources's stock price today?

  • The Idaho Strategic Resources share price today is $11.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDR is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

IDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 45.78 Sell
Chaikin Money Flow: 17191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.63 - 13.65) Sell
Bollinger Bands (100): (10.54 - 14.64) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

IDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.45 Buy
20-day SMA: 12.43 Sell
50-day SMA: 11.86 Sell
200-day SMA: 12.11 Sell
8-day EMA: 11.56 Sell
20-day EMA: 12.01 Sell
50-day EMA: 12.16 Sell
200-day EMA: 11.62 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Idaho Strategic Resources Earnings Growth & IDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Idaho Strategic Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):